Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis

Published:2017-09-07 Issue:17 Volume:2 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Stathopoulos Panos,Kumar Aditya,Nowak Richard J.,O’Connor Kevin C.

Funder

National Institutes of Health NIAID

Conquer Myasthenia Gravis

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/94263/files/pdf

Reference63 articles.

1. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

2. Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects

3. Clinical characteristics of refractory myasthenia gravis patients;Suh;Yale J Biol Med,2013

4. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis

5. Long-lasting treatment effect of rituximab in MuSK myasthenia

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serological Markers of Clinical Improvement in MuSK Myasthenia Gravis;Neurology Neuroimmunology & Neuroinflammation;2024-11

2. Myasthenia gravis: the future is here;Journal of Clinical Investigation;2024-06-17

3. Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis;Frontiers in Immunology;2024-06-06

4. Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities;Frontiers in Pharmacology;2024-05-27

5. A predictive nomogram for short‐term outcomes of myasthenia gravis patients treated with low‐dose rituximab;CNS Neuroscience & Therapeutics;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3